Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Replication factor C subunit 2 pseudogene is a non-coding DNA sequence in the human genome with high sequence similarity to the protein-coding **RFC2** gene, which encodes a 40 kDa subunit of replication factor C, an essential protein complex involved in DNA replication and repair. Pseudogenes such as this do not encode functional proteins and typically lack established biological functions. They are not considered therapeutic targets, enzymes, receptors, or transporters[7]. Some pseudogenes may regulate gene expression through mechanisms like competing endogenous RNA or microRNA sponging, but there is no evidence supporting such functions for this RFC2 pseudogene[7]. Accordingly, it does not have known interacting drugs, biomarker potential, or disease implications.\n\n**Key context:**\n- This entry is **not a valid therapeutic target**. The confusion may stem from its similarity to the true RFC2 gene, which is protein-coding and functionally relevant to DNA replication[1][3].\n- Pseudogenes are generally classified as "Other" in molecular taxonomy since they are non-coding and are not grouped with enzymes, receptors, or similar families[7].\n- There is no literature evidence that this particular pseudogene (ENSG00000224529 / LOC100533727) encodes a protein, has a role in disease, or is druggable or actionable in the sense of therapeutic intervention.\n\n**If you are seeking information on the functional RFC2 gene**, the appropriate canonical name would be "Replication factor C subunit 2", which codes for the 40 kDa subunit of the clamp loader complex essential for DNA replication and repair[1][3][5]. If you need datasheets for the protein-coding RFC2, request information for the gene identifier ENSG00000049541 or UniProt P35250.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Replication factor C subunit 2 pseudogene.